A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
Clinical trial NCT03792555 · COMPLETED
Trial details
- NCT number
- NCT03792555
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2020-07-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.